Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetes Mellitus
- Tuberculosis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04600167
- Collaborators
- Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands
- Otago University, New Zealand
- Makerere University
- St George's, University of London, United Kingdom
- Kilimanjaro Christian Medical University College (KCMUCo), Tanzania
- Uganda Martyrs Hospital Lubaga, Uganda
- King's College London
- Investigators
- Study Chair: Nyanda E Ntinginya, MD, MSc., Ph.D Mbeya Medical Research Center, National Institute for Medical Research, Tanzania Principal Investigator: Nyasatu Chamba, MD. Kilimanjaro Christian Medical Centre,Moshi,Tanzania Principal Investigator: Irene Andia- Biraro, MD., Ph.D. Makerere University, Makerere, Uganda Principal Investigator: Davis Kibirige, MD, Ph.D. Martyrs Hospital Lubaga, Makerere, Uganda